Systematic review of mulberry leaves for diabetes mellitus shows insufficient evidence due to lack of high-quality trials.

A systematic review was conducted to evaluate the use of mulberry leaves in the management of diabetes mellitus. The specific study design, population characteristics, and sample size were not reported in the available data. No comparator group or specific intervention details were provided in the input information.

The primary and secondary outcomes were not reported, preventing the calculation of effect sizes or statistical significance. Consequently, the main results regarding glycemic control or other metabolic parameters could not be determined from the provided text. Safety data, including adverse events, serious adverse events, discontinuations, and overall tolerability, were also not reported.

Key limitations of the current evidence include the absence of high-quality clinical studies and a lack of standardized dosage and formulation protocols. These gaps hinder the ability to draw definitive conclusions about the therapeutic potential of mulberry leaves for this condition. The review highlights that further rigorous research is required to establish reliable practice guidelines.

Given the incomplete data, the practice relevance remains uncertain. Clinicians should interpret these findings with caution and await results from future high-quality trials before considering mulberry leaves as a standard intervention for diabetes mellitus.